ArticleHealthcare policy = Politiques de sante2005
Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004.
Article in Healthcare policy = Politiques de sante, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Main drivers of diabetes pharmaceuticals expenditures: evidence from OECD countries and Iran.Journal of diabetes and metabolic disorders · 2023Article
- Factors Contributing to Increases in Prescription Drug Expenditures Borne by National Health Insurance in South Korea.Yonsei medical journal · 2016Article
- National pharmacare: Time to move forward.Canadian family physician Medecin de famille canadien · 2016Article
- [Assurance-médicaments nationale: Le moment d'aller de l'avant].Canadian family physician Medecin de famille canadien · 2016Article
- Do drugs reduce utilisation of other healthcare resources?PharmacoEconomics · 2007Article
- Income-based drug coverage in British Columbia: the impact on private and public expenditures.Healthcare policy = Politiques de sante · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This analysis uses a consistent pan-Canadian dataset--Canadian CompuScript from IMS Health, Canada--to quantify trends in per capita drug expenditures within each Canadian province over the period of 1998 to 2004. The impacts of changes in six potential determinants of drug expenditure are calculated for every province. Each of the six detailed cost drivers falls into one of three broad categories: volume effects, price effects and therapeutic choices. Despite wide variation in expenditure levels, the rate and causes of provincial expenditure trends over time were roughly comparable. From 1998 to 2004, per capita expenditures on oral solid prescription drugs grew at a rate of over 10% per year in most provinces--several times faster than economic growth over the same period. This rapid expenditure growth has largely been due to increased utilization of medicines and a trend towards prescribing higher-cost drugs over time. Price changes had little impact on drug spending in all provinces.
Identifiers
19308105PMC2585243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.